Subscribe to Newsletter

Advanced Medicine

Manufacture Advanced Medicine

Less Than 5 Percent Human Effort: Thoughts on the Role of Automation on Cell and Gene Therapy

| Dalip Sethi | 7 min read

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

Discovery & Development Analytical Science

The Genetic Advantage

| Kevin Clifford | 4 min read

Genetic insights may offer shortcuts along the clinical development pathway, bringing new therapeutics to market faster

Manufacture Advanced Medicine

Cell and Ex Vivo Gene Therapies: A Manufacturing Odyssey

| George Todorov | 17 min read

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

Discovery & Development Advanced Medicine

Between the Gut and the Stars

| Rob Coker | 4 min read

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Discovery & Development Drug Delivery

Lipid Nanoparticles: From Little League to the Majors

| Bowen Tian | 8 min read

What does the future hold for lipid nanoparticles?

Discovery & Development Translational Science

From Arctic Fish To New Cell Therapy Preservation Technologies

| Maryam Mahdi | 2 min read

Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.

Manufacture Advanced Medicine

The Nucleic Acid Revolution

| Tommy Duncan | 3 min read

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

Business & Regulation Business Practice

Who Are the Best Companies in the Pharma Field?

| 2 min read

Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!

Manufacture Advanced Medicine

Memories From the Start of the Gene Therapy Wave

| Stephanie Vine | 10 min read

The remarkable story of gene therapy drug development during the 1990s and early 2000s.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register